Atlas Trials

GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

Clinical trial NCT02224703 · COMPLETED

Trial details

NCT number
NCT02224703
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
EpilepsyDravet Syndrome
Start date
2015-04-13
Primary completion
2018-04-09
Enrollment
199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.